METSERA THERAPEUTICS
DEAD

Serial Number

97809057

Owner

Population Health Partners, L.P.

Attorney

David Cole

Filing Date

Feb 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

METSERA THERAPEUTICS Trademark

Serial Number: 97809057

METSERA THERAPEUTICS is a trademark filed by Population Health Partners, L.P. on February 23, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Population Health Partners, L.P. (7 trademarks)

1200 Morris Turnpike, Suite 3005
Short Hills, NJ 07078

Entity Type: 13

Trademark Details

Filing Date

February 23, 2023

Registration Date

Not Registered

Goods & Services

Medical software for the automated diagnosis of disease conditions from analysis of medical data

House mark for a full line of pharmaceuticals; pharmaceutical preparations

Providing healthcare administration, namely, providing insurance verification and prior authorization services for others; administration of patient reimbursement programs

Data collection and analysis services in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; business consulting and analysis services regarding information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications

Computer programming consultancy; Computer software consulting; Advanced product research in the field of artificial intelligence; Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare access to a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; Scientific and technological services, particularly scientific research and analysis, in the fields of medicine, health and wellness; design and development of computers and software; biomedical research; software development; scientific laboratory services; provision of information relating to medical and scientific research in the field of pharmaceutical products; software programming; in the fields of medicine, health, fitness, exercise and wellness

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 15, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 15, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 29, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2023 NWOS
NEW APPLICATION ENTERED
Feb 27, 2023 NWAP